ARTICLE | Clinical News
Incivek regulatory update
October 29, 2012 7:00 AM UTC
Johnson & Johnson reached an agreement on the price for HCV drug Incivo telaprevir with Germany's Statutory Health Insurance Funds Association (GKV-Spitzenverband). The company declined to disclose th...